Cleavage of Na+ channels by calpain increases persistent Na+ current and promotes spasticity after spinal cord injury

Abstract

Upregulation of the persistent sodium current (INaP) in motoneurons contributes to the development of spasticity after spinal cord injury (SCI). We investigated the mechanisms that regulate INaP and observed elevated expression of voltage-gated sodium (Nav) 1.6 channels in spinal lumbar motoneurons of adult rats with SCI. Furthermore, immunoblots revealed a proteolysis of Nav channels, and biochemical assays identified calpain as the main proteolytic factor. Calpain-dependent cleavage of Nav channels after neonatal SCI was associated with an upregulation of INaP in motoneurons. Similarly, the calpain-dependent cleavage of Nav1.6 channels expressed in human embryonic kidney (HEK) 293 cells caused the upregulation of INaP. The pharmacological inhibition of calpain activity by MDL28170 reduced the cleavage of Nav channels, INaP in motoneurons and spasticity in rats with SCI. Similarly, the blockade of INaP by riluzole alleviated spasticity. This study demonstrates that Nav channel expression in lumbar motoneurons is altered after SCI, and it shows a tight relationship between the calpain-dependent proteolysis of Nav1.6 channels, the upregulation of INaP and spasticity.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Figure 1: Upregulation of motoneuron AIS Nav α-subunits after SCI.
Figure 2: Cleavage of Nav1.6 channels by calpain.
Figure 3: Calpain inhibition prevents the cleavage of Nav channels and the INaP increase after SCI.
Figure 4: Riluzole decreases spasms in rats with SCI.
Figure 5: Calpain inhibition restores Nav expression and decreases spasms in rats with SCI.
Figure 6: Calpain inhibition has a long-lasting effect on the restoration of Nav expression and the reduction of spasms after SCI.

References

  1. 1

    Biering-Sørensen, F., Nielsen, J.B. & Klinge, K. Spasticity-assessment: a review. Spinal Cord 44, 708–722 (2006).

  2. 2

    Boulenguez, P. & Vinay, L. Strategies to restore motor functions after spinal cord injury. Curr. Opin. Neurobiol. 19, 587–600 (2009).

  3. 3

    Boulenguez, P. et al. Down-regulation of the potassium-chloride cotransporter KCC2 contributes to spasticity after spinal cord injury. Nat. Med. 16, 302–307 (2010).

  4. 4

    Harvey, P.J., Li, X., Li, Y. & Bennett, D.J. 5-HT2 receptor activation facilitates a persistent sodium current and repetitive firing in spinal motoneurons of rats with and without chronic spinal cord injury. J. Neurophysiol. 96, 1158–1170 (2006).

  5. 5

    Li, X., Murray, K., Harvey, P.J., Ballou, E.W. & Bennett, D.J. Serotonin facilitates a persistent calcium current in motoneurons of rats with and without chronic spinal cord injury. J. Neurophysiol. 97, 1236–1246 (2007).

  6. 6

    Heckman, C.J., Gorassini, M.A. & Bennett, D.J. Persistent inward currents in motoneuron dendrites: implications for motor output. Muscle Nerve 31, 135–156 (2005).

  7. 7

    Hounsgaard, J., Hultborn, H., Jespersen, B. & Kiehn, O. Bistability of α-motoneurones in the decerebrate cat and in the acute spinal cat after intravenous 5-hydroxytryptophan. J. Physiol. (Lond.) 405, 345–367 (1988).

  8. 8

    Li, Y., Gorassini, M.A. & Bennett, D.J. Role of persistent sodium and calcium currents in motoneuron firing and spasticity in chronic spinal rats. J. Neurophysiol. 91, 767–783 (2004).

  9. 9

    Gorassini, M.A., Knash, M.E., Harvey, P.J., Bennett, D.J. & Yang, J.F. Role of motoneurons in the generation of muscle spasms after spinal cord injury. Brain 127, 2247–2258 (2004).

  10. 10

    Murray, K.C. et al. Recovery of motoneuron and locomotor function after spinal cord injury depends on constitutive activity in 5-HT2C receptors. Nat. Med. 16, 694–700 (2010).

  11. 11

    Tazerart, S., Vinay, L. & Brocard, F. The persistent sodium current generates pacemaker activities in the central pattern generator for locomotion and regulates the locomotor rhythm. J. Neurosci. 28, 8577–8589 (2008).

  12. 12

    Brocard, F. et al. Activity-dependent changes in extracellular Ca2+ and K+ reveal pacemakers in the spinal locomotor-related network. Neuron 77, 1047–1054 (2013).

  13. 13

    Brocard, F., Tazerart, S. & Vinay, L. Do pacemakers drive the central pattern generator for locomotion in mammals? Neuroscientist 16, 139–155 (2010).

  14. 14

    Tazerart, S., Viemari, J.C., Darbon, P., Vinay, L. & Brocard, F. Contribution of persistent sodium current to locomotor pattern generation in neonatal rats. J. Neurophysiol. 98, 613–628 (2007).

  15. 15

    Bouhadfane, M., Tazerart, S., Moqrich, A., Vinay, L. & Brocard, F. Sodium-mediated plateau potentials in lumbar motoneurons of neonatal rats. J. Neurosci. 33, 15626–15641 (2013).

  16. 16

    Fukuoka, T., Kobayashi, K. & Noguchi, K. Laminae-specific distribution of alpha-subunits of voltage-gated sodium channels in the adult rat spinal cord. Neuroscience 169, 994–1006 (2010).

  17. 17

    Duflocq, A., Le Bras, B., Bullier, E., Couraud, F. & Davenne, M. Nav1.1 is predominantly expressed in nodes of Ranvier and axon initial segments. Mol. Cell. Neurosci. 39, 180–192 (2008).

  18. 18

    Croall, D.E. & Ersfeld, K. The calpains: modular designs and functional diversity. Genome Biol. 8, 218 (2007).

  19. 19

    von Reyn, C.R. et al. Calpain mediates proteolysis of the voltage-gated sodium channel α-subunit. J. Neurosci. 29, 10350–10356 (2009).

  20. 20

    Kunz, S. et al. The calpain inhibitor MDL 28170 prevents inflammation-induced neurofilament light chain breakdown in the spinal cord and reduces thermal hyperalgesia. Pain 110, 409–418 (2004).

  21. 21

    Arataki, S. et al. Calpain inhibitors prevent neuronal cell death and ameliorate motor disturbances after compression-induced spinal cord injury in rats. J. Neurotrauma 22, 398–406 (2005).

  22. 22

    Markgraf, C.G. et al. Six-hour window of opportunity for calpain inhibition in focal cerebral ischemia in rats. Stroke 29, 152–158 (1998).

  23. 23

    Harvey, P.J., Li, X., Li, Y. & Bennett, D.J. Endogenous monoamine receptor activation is essential for enabling persistent sodium currents and repetitive firing in rat spinal motoneurons. J. Neurophysiol. 96, 1171–1186 (2006).

  24. 24

    Harvey, P.J., Li, Y., Li, X. & Bennett, D.J. Persistent sodium currents and repetitive firing in motoneurons of the sacrocaudal spinal cord of adult rats. J. Neurophysiol. 96, 1141–1157 (2006).

  25. 25

    Li, Y. & Bennett, D.J. Persistent sodium and calcium currents cause plateau potentials in motoneurons of chronic spinal rats. J. Neurophysiol. 90, 857–869 (2003).

  26. 26

    Urbani, A. & Belluzzi, O. Riluzole inhibits the persistent sodium current in mammalian CNS neurons. Eur. J. Neurosci. 12, 3567–3574 (2000).

  27. 27

    Svenningsen, P. et al. Physiological regulation of epithelial sodium channel by proteolysis. Curr. Opin. Nephrol. Hypertens. 20, 529–533 (2011).

  28. 28

    Vallet, V., Chraibi, A., Gaeggeler, H.P., Horisberger, J.D. & Rossier, B.C. An epithelial serine protease activates the amiloride-sensitive sodium channel. Nature 389, 607–610 (1997).

  29. 29

    Armstrong, C.M., Bezanilla, F. & Rojas, E. Destruction of sodium conductance inactivation in squid axons perfused with pronase. J. Gen. Physiol. 62, 375–391 (1973).

  30. 30

    Undrovinas, A., Maltsev, V.A. & Sabbah, H.N. Calpain inhibition reduces amplitude and accelerates decay of the late sodium current in ventricular myocytes from dogs with chronic heart failure. PLoS One 8, e54436 (2013).

  31. 31

    Murray, K.C., Stephens, M.J., Ballou, E.W., Heckman, C.J. & Bennett, D.J. Motoneuron excitability and muscle spasms are regulated by 5-HT2B and 5-HT2C receptor activity. J. Neurophysiol. 105, 731–748 (2011).

  32. 32

    Palecek, J., Lips, M.B. & Keller, B.U. Calcium dynamics and buffering in motoneurones of the mouse spinal cord. J. Physiol. (Lond.) 520, 485–502 (1999).

  33. 33

    Kuo, J.J., Lee, R.H., Zhang, L. & Heckman, C.J. Essential role of the persistent sodium current in spike initiation during slowly rising inputs in mouse spinal neurones. J. Physiol. (Lond.) 574, 819–834 (2006).

  34. 34

    Schoch, K.M. et al. Brain injury-induced proteolysis is reduced in a novel calpastatin-overexpressing transgenic mouse. J. Neurochem. 125, 909–920 (2013).

  35. 35

    Hunanyan, A.S. et al. Alterations of action potentials and the localization of Nav1.6 sodium channels in spared axons after hemisection injury of the spinal cord in adult rats. J. Neurophysiol. 105, 1033–1044 (2011).

  36. 36

    Hains, B.C. & Waxman, S.G. Sodium channel expression and the molecular pathophysiology of pain after SCI. Prog. Brain Res. 161, 195–203 (2007).

  37. 37

    Craner, M.J. et al. Sodium channels contribute to microglia/macrophage activation and function in EAE and MS. Glia 49, 220–229 (2005).

  38. 38

    Zhou, H.Y. et al. N-methyl-D-aspartate receptor- and calpain-mediated proteolytic cleavage of K+-Cl cotransporter-2 impairs spinal chloride homeostasis in neuropathic pain. J. Biol. Chem. 287, 33853–33864 (2012).

  39. 39

    Banik, N.L., Matzelle, D.C., Gantt-Wilford, G., Osborne, A. & Hogan, E.L. Increased calpain content and progressive degradation of neurofilament protein in spinal cord injury. Brain Res. 752, 301–306 (1997).

  40. 40

    Springer, J.E., Azbill, R.D., Kennedy, S.E., George, J. & Geddes, J.W. Rapid calpain I activation and cytoskeletal protein degradation following traumatic spinal cord injury: attenuation with riluzole pretreatment. J. Neurochem. 69, 1592–1600 (1997).

  41. 41

    Schumacher, P.A., Eubanks, J.H. & Fehlings, M.G. Increased calpain I–mediated proteolysis, and preferential loss of dephosphorylated NF200, following traumatic spinal cord injury. Neuroscience 91, 733–744 (1999).

  42. 42

    Ray, S.K. et al. Calpain activity and translational expression increased in spinal cord injury. Brain Res. 816, 375–380 (1999).

  43. 43

    Li, Z., Hogan, E.L. & Banik, N.L. Role of calpain in spinal cord injury: increased calpain immunoreactivity in rat spinal cord after impact trauma. Neurochem. Res. 21, 441–448 (1996).

  44. 44

    Yu, C.G. et al. Calpain 1 knockdown improves tissue sparing and functional outcomes after spinal cord injury in rats. J. Neurotrauma 30, 427–433 (2013).

  45. 45

    Du, S. et al. Calcium influx and activation of calpain I mediate acute reactive gliosis in injured spinal cord. Exp. Neurol. 157, 96–105 (1999).

  46. 46

    Shields, D.C., Schaecher, K.E., Hogan, E.L. & Banik, N.L. Calpain activity and expression increased in activated glial and inflammatory cells in penumbra of spinal cord injury lesion. J. Neurosci. Res. 61, 146–150 (2000).

  47. 47

    Wienecke, J., Westerdahl, A.C., Hultborn, H., Kiehn, O. & Ryge, J. Global gene expression analysis of rodent motor neurons following spinal cord injury associates molecular mechanisms with development of postinjury spasticity. J. Neurophysiol. 103, 761–778 (2010).

  48. 48

    Cifra, A., Mazzone, G.L. & Nistri, A. Riluzole: what it does to spinal and brainstem neurons and how it does it. Neuroscientist 19, 137–144 (2013).

  49. 49

    Theiss, R.D., Hornby, T.G., Rymer, W.Z. & Schmit, B.D. Riluzole decreases flexion withdrawal reflex but not voluntary ankle torque in human chronic spinal cord injury. J. Neurophysiol. 105, 2781–2790 (2011).

  50. 50

    Zijdewind, I. & Thomas, C.K. Firing patterns of spontaneously active motor units in spinal cord–injured subjects. J. Physiol. (Lond.) 590, 1683–1697 (2012).

  51. 51

    Kitzman, P.H. Effectiveness of riluzole in suppressing spasticity in the spinal cord injured rat. Neurosci. Lett. 455, 150–153 (2009).

  52. 52

    Lampert, A., Hains, B.C. & Waxman, S.G. Upregulation of persistent and ramp sodium current in dorsal horn neurons after spinal cord injury. Exp. Brain Res. 174, 660–666 (2006).

  53. 53

    Hama, A. & Sagen, J. Antinociceptive effect of riluzole in rats with neuropathic spinal cord injury pain. J. Neurotrauma 28, 127–134 (2011).

  54. 54

    Grossman, R.G. et al. A prospective, multicenter, phase I matched-comparison group trial of safety, pharmacokinetics, and preliminary efficacy of riluzole in patients with traumatic spinal cord injury. J. Neurotrauma 31, 239–255 (2014).

  55. 55

    Ray, S.K. & Banik, N.L. Calpain and its involvement in the pathophysiology of CNS injuries and diseases: therapeutic potential of calpain inhibitors for prevention of neurodegeneration. Curr. Drug Targets CNS Neurol. Disord. 2, 173–189 (2003).

  56. 56

    Yu, C.G., Joshi, A. & Geddes, J.W. Intraspinal MDL28170 microinjection improves functional and pathological outcome following spinal cord injury. J. Neurotrauma 25, 833–840 (2008).

  57. 57

    Wang, K.K. Developing selective inhibitors of calpain. Trends Pharmacol. Sci. 11, 139–142 (1990).

  58. 58

    Mehdi, S. Cell-penetrating inhibitors of calpain. Trends Biochem. Sci. 16, 150–153 (1991).

  59. 59

    Goll, D.E., Thompson, V.F., Li, H., Wei, W. & Cong, J. The calpain system. Physiol. Rev. 83, 731–801 (2003).

  60. 60

    Wu, Y. et al. Delayed post-injury administration of riluzole is neuroprotective in a preclinical rodent model of cervical spinal cord injury. J. Neurotrauma 30, 441–452 (2013).

Download references

Acknowledgements

We dedicate this article to the memory of our dear colleague and friend Laurent Vinay, who passed away on 26 March 2015. Vinay was absolutely dedicated to science and, specifically, to the field of spinal cord research. Everyone who interacted with him was marked by his kindness, humanity and devotion. Vinay will leave a great void behind. This study was supported by the International Spinal Research Trust (to L.V.; STR110), the Fondation pour la Recherche Médicale (to L.V. and F.B.; DEQ20130326540) and the French Institut pour la Recherche sur la Moelle épinière et l'Encéphale (to F.B.). P.B. is supported by the French National Institute of Health and Medical Research (INSERM). We thank the company NSrepair for their help in surgery and postoperative care. We thank A.J. Powell and M. Bird for providing us with the HEK293 cell line stably expressing Nav1.6 (GlaxoSmithKline, Stevenage, UK).

Author information

C.B. designed and performed the immunohistochemistry, western blot and surgery. V.P. performed in vivo experiments, contributed to in vitro experiments and to surgery. P.B. designed and performed in vivo experiments. S.L. performed cell culture and participated in immunohistochemistry and western blot. M.B. participated in some in vitro experiments. A.V.-L. contributed to surgery and postoperative care. L.V. provided valuable expertise in the field of SCI research. F.B. designed and supervised the whole project and contributed to the in vitro experiments. C.B., V.P., P.B., L.V. and F.B. analyzed data. L.V. and F.B. wrote the manuscript.

Correspondence to Frédéric Brocard.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Supplementary information

Supplementary Text and Figures

Supplementary Figures 1–8 and Supplementary Tables 1–2 (PDF 1036 kb)

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Brocard, C., Plantier, V., Boulenguez, P. et al. Cleavage of Na+ channels by calpain increases persistent Na+ current and promotes spasticity after spinal cord injury. Nat Med 22, 404–411 (2016). https://doi.org/10.1038/nm.4061

Download citation

Further reading